Search for: "Anda Inc."
Results 41 - 60
of 960
Sorted by Relevance
|
Sort by Date
16 Apr 2012, 9:49 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
14 Jan 2020, 9:10 pm
The issue arose in ANDA litigation, where the District Court found claim 6 of U.S. [read post]
20 Jun 2013, 1:00 am
Actavis, Inc., the Supreme Court held that reverse payment (“pay-for-delay”) settlement agreements made in the context of settling Hatch-Waxman ANDA litigation should be evaluated for antitrust violations under a “rule of reason” analysis. [read post]
6 Aug 2009, 12:06 am
"Abraxis Bioscience, Inc. v. [read post]
12 Sep 2012, 1:46 pm
Impax Labs., Inc., C.A. [read post]
29 Jan 2013, 9:21 pm
Barr Laboratories, Inc., interesting. [read post]
1 Sep 2015, 9:59 pm
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
27 Nov 2022, 8:41 pm
Alvogen, Inc. [read post]
6 May 2019, 9:58 pm
The case arose in ANDA litigation over Mallinckrodt's U.S. [read post]
3 Jul 2012, 8:18 pm
By Andrew Williams -- On Monday, in Sciele Pharma Inc. v. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
7 Aug 2018, 8:20 am
ANI Pharmaceuticals, Inc., 2018 WL 3677923, No. 17-4910 (D. [read post]
16 Oct 2019, 9:59 pm
Actavis Laboratories UT, Inc. [read post]
20 Mar 2008, 1:55 am
Duramed Pharmaceuticals, Inc., SACV08-0243 JVS (C.D. [read post]
17 Jun 2013, 9:59 pm
Actavis, Inc. [read post]
20 Aug 2020, 9:59 pm
Noonan -- ANDA litigation, pursuant to the Hatch-Waxman Act, has become more complicated over the years since enactment of the statute in 1984, with more patents being asserted and more parties participating over the opportunity to market a generic version of a branded, innovator drug. [read post]
11 Aug 2010, 9:55 pm
By Donald Zuhn -- In Adams Respiratory Therapeutics, Inc. v. [read post]
30 Oct 2017, 9:49 pm
Teleflex Inc. [read post]
4 Oct 2010, 7:47 am
Sandoz Inc., C.A. [read post]
18 Aug 2022, 11:39 am
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]